Aligos Therapeutics Cash Flow Statement 2018-2024 | ALGS

Fifteen years of historical annual cash flow statements for Aligos Therapeutics (ALGS).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-87.68$-96.05$-128.33$-108.54$-52.26$-13.93
$2.65$3.52$3.86$3.56$1.42$1.74
$15.56$14.69$13.46$14.66$0.40$1.26
$18.21$18.21$17.32$18.22$1.83$3.00
$0$0$0$0$0$0
$0$0$0$0$0$0
$-1.30$-7.42$9.43$9.44$4.61$6.16
$-8.22$5.87$-14.08$6.63$-0.94$-1.28
$-9.53$-1.55$-4.65$16.06$3.67$4.89
$-79.00$-79.39$-115.66$-74.26$-46.77$-6.05
$-0.02$-0.94$-0.89$-2.06$-2.79$-2.52
$0$0$0$0$0$0
$0$0$0$0$0$0
$45.00$-25.35$20.30$48.00$19.60$-66.77
$0$0$-16.39$-13.18$-10.02$0
$45.00$-25.35$3.91$34.82$9.58$-66.77
$0$0$0$0$0$0
$44.98$-26.29$3.02$32.76$6.79$-69.29
$-0.10$-0.06$-0.08$-0.06$-0.04$5.00
$0$0$0$0$0$0
$-0.10$-0.06$-0.08$-0.06$-0.04$5.00
$70.98$0.23$79.63$157$0.61$0.08
$70.98$0.23$79.63$197$85.58$94.89
$0$0$0$0$0$0
$17.44$0$-0.88$-4.52$0$0
$88.33$0.16$78.68$192$85.53$99.89
$54.31$-105.52$-33.96$151$45.56$24.55
$12.65$14.69$13.46$2.98$0.75$0.18
$0$0$0$0$0$0